The Journal of Immunology, Vol 142, Issue 4 1245-1252, Copyright © 1989 by American Association of Immunologists

ARTICLES

Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells

AA Amoscato, JW Alexander and GF Babcock
Department of Surgery, University of Cincinnati College of Medicine, OH 45267-0558.

Surface aminopeptidase activity in intact lymphocytes was studied and was shown to have the following properties when alanine-p-nitroanilide was used as substrate: 1) The activity was surface associated and not secreted as determined by extracellular location of product and the effect of proteases and diazotized sulfanilic acid on enzyme activity. 2) The enzyme activity was shown to have a pH optimum of 7.4 to 8.0. 3) Enzyme activity was shown to be inhibited by amastatin, bestatin, and 1,10 phenanthroline. Inhibition by amastatin consisted of a high- affinity component (Ki = 3.5 x 10(-6) M) which accounted for approximately 20% of the total activity and a low-affinity component (Ki = 3.5 x 10(-5) M) which accounted for the remainder suggesting that two forms of aminopeptidase exist. Only a single component of inhibition was seen with bestatin (Ki = 3.5 x 10(-6) M) and 1,10 phenanthroline (Ki = 2.0 x 10(-4) M) which accounted for 80 and 90% of the total enzyme activity, respectively. Unlike the competitive inhibitors bestatin and amastatin, inhibition by 1,10 phenanthroline was shown to be non-competitive. Finally, surface aminopeptidase activity essentially doubled in the presence of PHA (10 micrograms/ml) or Con A (10 micrograms/ml), at 72 h. This enhancing effect was shown to be dose dependent, time dependent, and mitogen dependent and correlated with the cellular state of activation as determined by [3H]TdR incorporation.

This article has been cited by other articles:

				M. Stankovic, P. Vlahovic, V. Avramovic, and M. Todorovic Distribution of Dipeptidyl Peptidase IV in Patients with Chronic Tonsillitis Clin. Vaccine Immunol., May 1, 2008; 15(5): 794 - 798. [Abstract] [Full Text] [PDF]

				R. Rangel, Y. Sun, L. Guzman-Rojas, M. G. Ozawa, J. Sun, R. J. Giordano, C. S. Van Pelt, P. T. Tinkey, R. R. Behringer, R. L. Sidman, et al. Impaired angiogenesis in aminopeptidase N-null mice PNAS, March 13, 2007; 104(11): 4588 - 4593. [Abstract] [Full Text] [PDF]

				H. Zhang, J. Tan, E. Reynolds, D. Kuebler, S. Faulhaber, and M. Tanouye The Drosophila slamdance Gene: A Mutation in an Aminopeptidase Can Cause Seizure, Paralysis and Neuronal Failure Genetics, November 1, 2002; 162(3): 1283 - 1299. [Abstract] [Full Text] [PDF]

				M. Rosenzwajg, L. Tailleux, and J. C. Gluckman CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells Blood, January 15, 2000; 95(2): 453 - 460. [Abstract] [Full Text] [PDF]

				X. Dong, B. An, L. Salvucci Kierstead, W. J. Storkus, A. A. Amoscato, and R. D. Salter Modification of the Amino Terminus of a Class II Epitope Confers Resistance to Degradation by CD13 on Dendritic Cells and Enhances Presentation to T Cells J. Immunol., January 1, 2000; 164(1): 129 - 135. [Abstract] [Full Text] [PDF]

				R. Babst, L. Bongiorno, M. Marini, L. G. Roda, G. Spagnoli, and A. Urbani Trauma Decreases Leucine Enkephalin Hydrolysis in Human Plasma J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 766 - 773. [Abstract] [Full Text]

				A. A. Amoscato, D. A. Prenovitz, and M. T. Lotze Rapid Extracellular Degradation of Synthetic Class I Peptides by Human Dendritic Cells J. Immunol., October 15, 1998; 161(8): 4023 - 4032. [Abstract] [Full Text] [PDF]